Home > Insider Trading > Filing (0001209191-17-031677)

Filing Details

Accession Number:: 0001209191-17-031677
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-11 20:34:23
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-11
Accepted Time:: 2017-05-11 20:34:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1180262	Herbalife Ltd.	HLF	Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1615466	Jesus Alzarez	800 W. Olympic Blvd. Los Angeles CA 90015	Vp, General Manager, Mexico	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-09	873	$62.51	873	No	4	M	Direct
Common Stock	Disposition	2017-05-09	750	$72.81	123	No	4	D	Direct
Common Stock	Disposition	2017-05-09	44	$72.81	79	No	4	F	Direct
Common Stock	Acquisiton	2017-05-09	3,464	$59.98	3,543	No	4	M	Direct
Common Stock	Disposition	2017-05-09	2,854	$72.81	689	No	4	D	Direct
Common Stock	Disposition	2017-05-09	214	$72.81	475	No	4	F	Direct
Common Stock	Acquisiton	2017-05-09	1,957	$30.44	2,432	No	4	M	Direct
Common Stock	Disposition	2017-05-09	819	$72.81	1,613	No	4	D	Direct
Common Stock	Disposition	2017-05-09	399	$72.81	1,214	No	4	F	Direct
Common Stock	Disposition	2017-05-11	1,214	$71.53	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	873	$0.00	873	$62.51
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	3,464	$0.00	3,464	$59.98
Common Stock	Stock Appreciation Rights	Disposition	2017-05-09	1,957	$0.00	1,957	$30.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,493	2017-05-09	2026-05-09	No	4	M	Direct
0	2017-04-30	2024-04-30	No	4	M	Direct
5,873	2017-03-02	2025-03-02	No	4	M	Direct

Footnotes

The reporting person received 79 shares of common stock upon the net exercise of the 873 stock appreciation rights ("SARs"). The reporting person forfeited 750 shares of common stock underlying Stock Appreciation Rights ("SARS") in payment of the exercise price and 44 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
The reporting person received 396 shares of common stock upon the net exercise of the 3,464 SARS. The reporting person forfeited 2,854 shares of common stock underlying the SARS in payment of the exercise price and 214 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
The reporting person received 739 shares of common stock upon the net exercise of the 1,957 SARS. The reporting person forfeited 819 shares of common stock underlying the SARS in payment of the exercise price and 399 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.
This transaction was executed in multiple trades at prices ranging from $71.52 to $71.53. The price reported reflects the weighted average sale price of $71.5275. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Consists of 4,366 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on May 9, 2017, 20% will vest on May 9, 2018, and the remaining 60% will vest on May 9, 2019.
Consists of 9,787 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.